Use of immunoblot assay to define serum antibody patterns associated with Helicobacter pylori infection and with H. pylori-related ulcers

Journal of Clinical Microbiology

Volumn 36, Issue 4, 1998, Pages 931-936

  Aucher, P ^a   Petit, M L ^a   Mannant, P R ^a   Pezennec, L ^a   Babin, P ^a   Fauchere, J L ^a,b  

^a UNIVERSITÉ DE POITIERS   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CHRONIC GASTRITIS; DISEASE MARKER; ENZYME IMMUNOASSAY; FEMALE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; SCHOOL CHILD; SEROLOGY;

HELICOBACTER PYLORI;

EID: 0031944221     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.4.931-936.1998     Document Type: Article

References (50)

1. Andersen, L. P. 1993. The antibody response to Helicobacter pylori infection, and the value of serologic tests to detect H. pylori and for post-treatment monitoring, p. 285-306. In C. S. Goodwin and B. W. Worsley (ed.), Helicobacter pylori: biology and clinical practice. CRC Press, Boca Raton, Fla.
2. Bazillou, M., C. Fendri, O. Castel, P. Ingrand, and J. L. Fauchère. 1994. Serum antibody response to the superficial and released components of Helicobacter pylori. Clin. Diagn. Lab. Immunol. 1:310-317.
3. Blaser, M. J., and J. Parsonnet. 1994. Parasitism by the "slow" bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J. Clin. Invest. 94:4-8.
4. Blaser, M. J., G. Perez-Perez, H. Kleanthous, T. L. Cover, R. M. Peek, P. H. Chyou, G. N. Stemmermann, and A. Nomura. 1995. Infection with Helicobacter pylori strains possessing cagA is associated with increased risk of developing adenocarcinoma of the stomach. Cancer. Res. 55:2111-2115.
5. Calam, J. 1993. The pathogenesis of Helicobacter pylori infection and duodenal ulcer: the role of gastrin and other soluble factors, p. 239-256. In C. S. Goodwin and B. W. Worsley (ed.), Helicobacter pylori: biology and clinical practice. CRC Press, Boca Raton, Fla.
6. Covacci, A., S. S. Censini, M. Bugnoli, R. Petracca, D. Burroni, G. Machia, A. Massone, E. Papini, Z. Xiang, and N. Figura. 1993. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc. Natl. Acad. Sci. USA 90:5791-5795.
7. Cover, T. L., and M. J. Blaser. 1992. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J. Biol. Chem. 267:10570-10575.
8. Cover, T. L., M. K. R. Tummuru, P. Cao, S. A. Thompson, and M. J. Blaser. 1994. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J. Biol. Chem. 269:10566-10573.
9. Cover, T. L., and M. J. Blaser. 1995. Helicobacter pylori: a bacterial cause of gastritis, peptic ulcer disease, and gastric cancer. ASM News 61:21-26.
10. + Helicobacter pylori strains. J. Clin. Microbiol. 33:1496-1500.
11. Dunn, B., G. P. Campbell, G. I. Perez-Perez, and M. J. Blaser. 1990. Purification and characterization of urease from Helicobacter pylori. J. Biol. Chem. 265:9464-9469.
12. Dunn, B. E., R. M. Roop II, C. C. Sung, S. A. Sharma, G. I. Perez-Perez, and M. J. Blaser. 1992. Identification and purification of a cpn60 heat shock protein homolog from Helicobacter pylori. Infect. Immun. 60:1946-1951.
13. Fauchère, J. L., and M. J. Blaser. 1990. Adherence of Helicobacter pylori cells and their surface components to HeLa cell membranes. Microb. Pathog. 9:427-439.
14. Fauchère, J. L. 1996. Evaluation of the anti-Helicobacter pylori serum antibody response, p. 50-74. In A. Lee and F. Mégraud (ed.), Helicobacter pylori: techniques for clinical diagnosis and basic research. W. B. Saunders Co., Philadelphia, Pa.
15. Fauchère, J. L. 1996. Réponse immunitaire contre Helicobacter pylori, p. 219-234. In F. Mégraud and H. Lamouliatte (ed.), Helicobacter pylori. Elsevier, Paris, France.
16. Faulde, M., J. P. Schröder, and D. Sobe. 1992. Serodiagnosis of Helicobacter pylori infections by detection of immunoglobulin G antibodies using an immunoblot technique and enzyme immunoassay. Eur. J. Clin. Microbiol. Infect. Dis. 11:589-594.
17. Forman, D. 1996. Helicobacter pylori and gastric cancer. Scand. J. Gastroenterol. 31(Suppl. 215):48-51.
18. Gormally, S., P. Sherman, and B. Drumm. 1993. Clinical syndromes of Helicobacter pylori infection in children, p. 85-94. In C. S. Goodwin and B. W. Worsley (ed.), Helicobacter pylori: biology and clinical practice. CRC Press, Boca Raton, Fla.
19. Guruge, J. L., C. Schalen, I. Nilsson, A. Ljungh, T. Tyzkiewic, M. Wikander, and T. Wadström. 1990. Detection of antibodies to Helicobacter pylori cell surface antigens. Scand. J. Infect. Dis. 22:457.
20. Jensen, A. K. V., L. P. Andersen, and C. H. Wachman. 1993. Evaluation of eight commercial kits for Helicobacter pylori IgG antibody detection. APMIS 101:795-801.
21. Klaamas, K., M. Held, T. Wadström, A. Lipping, and O. Kurtenkov. 1996. IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int. J. Cancer 67:1-5.
22. Kreuning, J., J. Lindeman, I. Biemond, and C. B. H. Lamers. 1994. Relation between IgG and IgA antibody titers against Helicobacter pylori in serum and severity of gastritis in asymptomatic subjects. J. Clin. Pathol. 47:227-231.
23. Labigne, A. 1995. Pouvoir pathogène de Helicobacter pylori. Ann. Inst. Pasteur/Actualités 6:167-178.
24. Labigne, A. 1996. Pouvoir pathogène de Helicobacter pylori, p. 119-140. In F. Mégraud and H. Lamouliatte (ed.), Helicobacter pylori. Elsevier, Paris, France.
25. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
26. Langar, H., P. Aucher, and J. L. Fauchère. Unpublished data.
27. Leunk, R. D., P. T. Johnson, B. C. David, W. G. Kraft, and D. R. Morgan. 1988. Cytotoxic activity in broth-culture filtrates of Campylobacter pylori. J. Med. Microbiol. 26:93-99.
28. Lozniewski, A., P. Aucher, J. D. de Korwin, and J. L. Fauchère. 1996. Méthodes sérologiques pour l'infection à Helicobacter pylori, p. 349-366. In F. Mégraud and H. Lamouliatte (ed.), Helicobacter pylori. Elsevier, Paris, France.
29. Mégraud, F. 1996. Stratégie d'utilisation des tests diagnostiques dans l'infection à Helicobacter pylori, p. 367-383. In F. Mégraud and H. Lamouliatte (ed.), Helicobacter pylori. Elsevier, Paris, France.
30. Mitchell, H. M. 1993. The epidemiology of Helicobacter pylori infection and its relation to gastric cancer, p. 95-114. In C. S. Goodwin and B. W. Worsley (ed.), Helicobacter pylori: biology and clinical practice. CRC Press, Boca Raton, Fla.
31. Mitchell, H. M., L. S. L. Hazell, T. Kolesnikow, J. Mitchell, and D. Frommer. 1996. Antigen recognition during progression from acute to chronic infection with a cagA-positive strain of Helicobacter pylori. Infect. Immun. 64:1166-1172.
32. Moran, A. P. 1996. Pathogenic properties of Helicobacter pylori. Scand. J. Gastroenterol. 31:22-31.
33. Morgan, D. R., and R. D. Leuk. 1989. Pathogenesis of infection by C. pylori, p. 115-134. In M. J. Blaser (ed.), Campylobacter pylori in gastritis and peptic ulcer disease. Igaku-Shoin Publishers, Inc., New York, N.Y.
34. Nilsson, I., A. Ljungh, P. Aleljung, and T. Wadström. 1997. Immunoblot assay for scrodiagnosis of Helicobacter pylori infections. J. Clin. Microbiol. 35:427-432.
35. Olivieri, R., M. Bugnoli, D. Armellini, S. Bianciardi, R. Rappuoli, P. F. Bayeli, L. Abate, E. Esposito, L. de Gregoria, J. Aziz, C. Basagni, and N. Figura. 1993. Growth of Helicobacter pylori in media containing cyclodextrins. J. Clin. Microbiol. 31:161-162.
36. Phadnis, S. H., D. Ilver, L. Janzon, S. Normark, and T. U. Westblom. 1994. Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori. Infect. Immun. 62:1557-1565.
37. Price, A. B. 1991. The Sydney system: histological division. J. Gastroenterol. Hepatol. 6:209-222.
38. Pronovost, A. D., S. L. Rose, J. W. Pawlak, H. Robin, and R. Schneider. 1994. Evaluation of a new immunodiagnostic assay for Helicobacter pylori antibody detection: correlation with histopathological and microbiological results. J. Clin. Microbiol. 32:46-50.
39. Ricci, V., C. Ciacci, R. Zarrilli, P. Sommi, M. K. R. Tummuru, C. Del Vecchio Blanco, C. B. Bruni, T. L. Cover, M. J. Blaser, and M. Romano. 1996. Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: role of VacA and CagA. Infect. Immun. 64:2829-2833.
40. Talley, N. J., and K. B. Noack. 1993. The worldwide prevalence of Helicobacter pylori: asymptomatic infection and clinical states associated with infection in adults, p. 63-84. In C. S. Goodwin and B. W. Worsley (ed.), Helicobacter pylori: biology and clinical practice. CRC Press, Boca Raton, Fla.
41. Tee, W., J. R. Lambert, and B. Dwyer. 1995. Cytotoxin production by Helicobacter pylori from patients with upper gastrointestinal tract diseases. J. Clin. Microbiol. 33:1203-1205.
42. Telford, J. L., P. Ghiara, M. Dell'Orco, M. Comanducci, D. Burroni, M. Bugnoli, M. F. Tecce, S. Censini, A. Covaccin, Z. Xiang, E. Paini, C. Montecucco, L. Parent, and R. Rappuoli. 1994. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J. Exp. Med. 179:1653-1658.
43. Tummuru, M. K. R., T. L. Cover, and M. J. Blaser. 1994. Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori. Infect. Immun. 62:2609-2613.
44. van de Wouw, B. A. M., W. A. de Boer, A. R. Jansz, R. T. J. Roymans, and A. P. G. Staals. 1996. Comparison of three commercially available enzyme-linked immunosorbent assays and biopsy-dependent diagnosis for detecting Helicobacter pylori infection. J. Clin. Microbiol. 34:94-97.
45. Veel, J. F. L., R. W. M. van der Hulst, Y. Gerrits, P. Roorda, M. Feller, J. Dankert, G. N. J. Tytgat, and A. van der Ende. 1996. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J. Infect. Dis. 173:1171-1175.
46. Vyas, S. K., D. Sharpstone, J. Treasure, D. Fine, and P. R. Hawtin. 1994. Pre-endoscopy screening using serodiagnosis of Helicobacter pylori infection. Eur. J. Gastroenterol. Hepatol. 6:783-785.
47. Wang, W. M., C. Y. Chen, C. M. Jan, L. T. Chen, D. S. Perng, S. R. Lin, and C. S. Liu. 1994. Long-term follow-up and serological study after triple therapy of Helicobacter pylori-associated duodenal ulcer. Am. J. Gastroenterol. 89:1793-1798.
48. Widmer, M., J. D. de Korwin, P. Aucher, J. M. Thibergue, A. Labigne, and J. E. Fauchère. 1996. Performance of native and recombinant antigens for Helicobacter pylori serology, abstr. 4C:47. In Proceedings of the IX International Workshop on Gastroduodenal Pathology and Helicobacter pylori. (Gut 39(Suppl. 2.)
49. Xiang, Z., M. Bugnoli, A. Ponzetto, A. Morgando, N. Figura, A. Covacci, R. Petracca, C. Pennatini, S. Censini, D. Armellini, and R. Rappuoli. 1993. Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori. Eur. J. Microbiol. Infect. Dis. 12:739-745.
50. Xiang, Z., S. Censini, P. F. Bayeli, J. L. Telford, N. Figura, R. Rappuoli, and A. Covacci. 1995. Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect. Immun. 63:94-98.